ADAGIO MEDICAL HOLDINGS, INC. Impairment of Long-Lived Assets Held-for-use
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2026-06-30 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2026-03-31 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2025-06-30 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. impairment of long-lived assets held-for-use for the quarter ending 2025-03-31 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use | Impairment of Long-Lived Assets Held-for-use 1 month | Impairment of Long-Lived Assets Held-for-use 2 month | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 7 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-08-11 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-08-11 | |||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | |||||
| 2024-07-31 | $0.00 10-Q · filed 2025-11-12 | |||||
| 2024-07-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 10-K · filed 2025-03-27 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |